Peptide Therapeutics Industry Report 2024, Featuring Profiles of 30+ Leading Players Including PeptiDream, PolyPeptide, Repligen, X-GEN Pharmaceuticals, Zydus Cadila and More
October 14, 2024 11:15 ET
|
Research and Markets
Dublin, Oct. 14, 2024 (GLOBE NEWSWIRE) -- The "Peptide Therapeutics - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Peptide...
High Potency APIs (HPAPIs) Strategic Research Report 2024: Global Market to Reach $46.9 Billion by 2030, Driven by Expansion of Oncology, Hormonal, and Endocrine Therapies
October 10, 2024 11:02 ET
|
Research and Markets
Dublin, Oct. 10, 2024 (GLOBE NEWSWIRE) -- The "High Potency APIs (HPAPIs) - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for High...
The State of the Biopharmaceutical Industry 2024 Edition (Mid-Year Update): Anti-Obesity Medications Take Center Stage
July 03, 2024 04:06 ET
|
Research and Markets
Dublin, July 03, 2024 (GLOBE NEWSWIRE) -- The "State of the Biopharmaceutical Industry 2024 Edition (Mid-Year Update)" report has been added to ResearchAndMarkets.com's offering.Although the...
Japan Contract Development Manufacturing Organization Market Report 2024-2030, Featuring Lonza, Recipharm, LabCorp, Catalent, WuXi AppTec, CordenPharma, Cambrex, Bushu Pharmaceuticals and Nipro
June 21, 2024 04:50 ET
|
Research and Markets
Dublin, June 21, 2024 (GLOBE NEWSWIRE) -- The "Japan Contract Development Manufacturing Organization Market Size, Share & Trends Analysis Report by Product Type (API, Drug Product), Workflow...
Global PEGylated Proteins Market Report 2024: Revenue Data for 2021-2022, Estimates for 2023, Forecasts for 2024, and CAGR Projections through 2028
May 08, 2024 10:30 ET
|
Research and Markets
Dublin, May 08, 2024 (GLOBE NEWSWIRE) -- The "PEGylated Proteins Market 2023-2028" report has been added to ResearchAndMarkets.com's offering. The global market for PEGylated proteins is expected...
Global Pharmaceutical CDMO Market Analysis Report 2024-2030: AI-Assisted Drug Active Pharmaceutical Ingredient (API) Synthesis Gaining Attention
April 08, 2024 10:26 ET
|
Research and Markets
Dublin, April 08, 2024 (GLOBE NEWSWIRE) -- The "Global Pharmaceutical CDMO Market Size, Share & Trends Analysis Report by Product (API, Drug Product), Workflow (Clinical, Commercial),...
Global Active Pharmaceutical Ingredient CDMO Market Projected to Reach USD 164.5 Billion by 2030
March 29, 2024 05:36 ET
|
Research and Markets
Dublin, March 29, 2024 (GLOBE NEWSWIRE) -- The "Active Pharmaceutical Ingredient CDMO Market Size, Share & Trends Analysis Report By Product, By Synthesis, By Drug, By Application, By Workflow,...
Global Highly Potent API (Active Pharmaceutical Ingredient) Industry Research 2023-2033: Growing Emphasis on Personalized Medicine & Increasing Opportunities for Pharma Companies in Developing Markets
March 29, 2024 05:02 ET
|
Research and Markets
Dublin, March 29, 2024 (GLOBE NEWSWIRE) -- The "Highly Potent API Market - A Global and Regional Analysis: Focus on Type, Type of Synthesis, Therapeutic Area, Type of Manufacturing, End User, and...
Global Antibody Contract Manufacturing Market Report 2023 with Profiles of Leading Players AbbVie, Samsung Biologics, Aenova, Cambrex, Eurofins Scientific, AGC Biologics and More
November 30, 2023 04:03 ET
|
Research and Markets
Dublin, Nov. 30, 2023 (GLOBE NEWSWIRE) -- The "Global Antibody Contract Manufacturing Market 2023" report has been added to ResearchAndMarkets.com's offering.The global antibody contract...
Global Active Pharmaceutical Ingredient CDMO Market to Reach $156.3 Billion by 2030, Driven by Rising R&D Investments and Demand for Generic Drugs
November 10, 2023 08:03 ET
|
Research and Markets
Dublin, Nov. 10, 2023 (GLOBE NEWSWIRE) -- The "Active Pharmaceutical Ingredient CDMO Market Size, Share & Trends Analysis Report By Product (Highly Potent API, Antibody Drug Conjugate), By...